Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Effect of human rotavirus vaccine on severe diarrhea in African infants.

Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM.

Malawi Med J. 2016 Sep;28(3):108-114.

2.

Measuring indirect effects of rotavirus vaccine in low income countries.

Bennett A, Bar-Zeev N, Cunliffe NA.

Vaccine. 2016 Aug 17;34(37):4351-3. doi: 10.1016/j.vaccine.2016.07.001.

3.

Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination.

Steele AD, Madhi SA, Cunliffe NA, Vesikari T, Phua KB, Lim FS, Nelson EA, Lau YL, Huang LM, Karkada N, Debrus S, Han HH, Benninghoff B.

Hum Vaccin Immunother. 2016 Sep;12(9):2406-12. doi: 10.1080/21645515.2016.1179412.

4.

Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study.

Mvula H, Heinsbroek E, Chihana M, Crampin AC, Kabuluzi S, Chirwa G, Mwansambo C, Costello A, Cunliffe NA, Heyderman RS, French N, Bar-Zeev N; VacSurv Consortium..

PLoS One. 2016 May 6;11(5):e0154997. doi: 10.1371/journal.pone.0154997.

5.

Early Detection of Epidemic GII-4 Norovirus Strains in UK and Malawi: Role of Surveillance of Sporadic Acute Gastroenteritis in Anticipating Global Epidemics.

Allen DJ, Trainor E, Callaghan A, O'Brien SJ, Cunliffe NA, Iturriza-Gómara M.

PLoS One. 2016 Apr 26;11(4):e0146972. doi: 10.1371/journal.pone.0146972.

6.

Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.

Bar-Zeev N, Tate JE, Pecenka C, Chikafa J, Mvula H, Wachepa R, Mwansambo C, Mhango T, Chirwa G, Crampin AC, Parashar UD, Costello A, Heyderman RS, French N, Atherly D, Cunliffe NA; VACSURV Consortium..

Clin Infect Dis. 2016 May 1;62 Suppl 2:S220-8. doi: 10.1093/cid/civ1025.

7.

Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses.

Bar-Zeev N, Jere KC, Bennett A, Pollock L, Tate JE, Nakagomi O, Iturriza-Gomara M, Costello A, Mwansambo C, Parashar UD, Heyderman RS, French N, Cunliffe NA; Vaccine Effectiveness and Disease Surveillance Programme, Malawi (VACSURV) Consortium..

Clin Infect Dis. 2016 May 1;62 Suppl 2:S213-9. doi: 10.1093/cid/civ1183.

8.

Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings.

King C, Beard J, Crampin AC, Costello A, Mwansambo C, Cunliffe NA, Heyderman RS, French N, Bar-Zeev N; VacSurv Consortium..

Vaccine. 2015 Sep 11;33(38):4748-55. doi: 10.1016/j.vaccine.2015.07.062. Review.

9.

Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.

Bar-Zeev N, Kapanda L, King C, Beard J, Phiri T, Mvula H, Crampin AC, Mwansambo C, Costello A, Parashar U, Tate JE, Verani JR, Whitney CG, Heyderman RS, Cunliffe NA, French N; VacSurv Consortium..

Vaccine. 2015 May 28;33(23):2637-45. doi: 10.1016/j.vaccine.2015.04.053.

10.

Determination of a Viral Load Threshold To Distinguish Symptomatic versus Asymptomatic Rotavirus Infection in a High-Disease-Burden African Population.

Bennett A, Bar-Zeev N, Jere KC, Tate JE, Parashar UD, Nakagomi O, Heyderman RS, French N, Iturriza-Gomara M, Cunliffe NA.

J Clin Microbiol. 2015 Jun;53(6):1951-4. doi: 10.1128/JCM.00875-15.

11.

Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.

Bar-Zeev N, Kapanda L, Tate JE, Jere KC, Iturriza-Gomara M, Nakagomi O, Mwansambo C, Costello A, Parashar UD, Heyderman RS, French N, Cunliffe NA; VacSurv Consortium..

Lancet Infect Dis. 2015 Apr;15(4):422-8. doi: 10.1016/S1473-3099(14)71060-6.

12.

Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination.

Gurgel RQ, Alvarez Ade J, Rodrigues A, Ribeiro RR, Dolabella SS, Da Mota NL, Santos VS, Iturriza-Gomara M, Cunliffe NA, Cuevas LE.

PLoS One. 2014 Oct 31;9(10):e110217. doi: 10.1371/journal.pone.0110217.

13.

Potential barriers to healthcare in Malawi for under-five children with cough and fever: a national household survey.

Ustrup M, Ngwira B, Stockman LJ, Deming M, Nyasulu P, Bowie C, Msyamboza K, Meyrowitsch DW, Cunliffe NA, Bresee J, Fischer TK.

J Health Popul Nutr. 2014 Mar;32(1):68-78.

14.

Campylobacter infection in children in Malawi is common and is frequently associated with enteric virus co-infections.

Mason J, Iturriza-Gomara M, O'Brien SJ, Ngwira BM, Dove W, Maiden MC, Cunliffe NA.

PLoS One. 2013;8(3):e59663. doi: 10.1371/journal.pone.0059663.

15.

Continued Circulation of G12P[6] Rotaviruses Over 28 Months in Nepal: Successive Replacement of Predominant Strains.

Gauchan P, Nakagomi T, Sherchand JB, Yokoo M, Pandey BD, Cunliffe NA, Nakagomi O.

Trop Med Health. 2013 Mar;41(1):7-12. doi: 10.2149/tmh.2012-28.

16.

G8 rotaviruses with conserved genotype constellations detected in Malawi over 10 years (1997-2007) display frequent gene reassortment among strains co-circulating in humans.

Nakagomi T, Doan YH, Dove W, Ngwira B, Iturriza-Gómara M, Nakagomi O, Cunliffe NA.

J Gen Virol. 2013 Jun;94(Pt 6):1273-95. doi: 10.1099/vir.0.050625-0.

17.

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.

Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd S, Louw C, Kirsten M, Aspinall S, Van Doorn LJ, Bouckenooghe A, Suryakiran PV, Han HH.

BMC Infect Dis. 2012 Sep 13;12:213. doi: 10.1186/1471-2334-12-213.

18.

Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial.

Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, Chimpeni P, Victor JC, Steele AD, Bouckenooghe A, Neuzil KM.

Vaccine. 2012 Apr 27;30 Suppl 1:A36-43. doi: 10.1016/j.vaccine.2011.09.120.

19.

Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi.

Nakagomi T, Nakagomi O, Dove W, Doan YH, Witte D, Ngwira B, Todd S, Duncan Steele A, Neuzil KM, Cunliffe NA.

Vaccine. 2012 Apr 27;30 Suppl 1:A140-51. doi: 10.1016/j.vaccine.2011.09.119.

20.

Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom.

Cunliffe NA, Booth JA, Elliot C, Lowe SJ, Sopwith W, Kitchin N, Nakagomi O, Nakagomi T, Hart CA, Regan M.

Emerg Infect Dis. 2010 Jan;16(1):55-62. doi: 10.3201/eid1601.090401.

Items per page

Supplemental Content

Loading ...
Support Center